ABIVAX SA-ADR
ABVXNASDAQ🏆 #723 by market capEarnings Sep 21US Equity
$126.81▼ $0.68 (−0.54%)
🌅 Pre-market$127.66▲ 0.67%Regular close · extended-hours price shown1h—
24h▼ 0.5%
7d▲ 1.2%
14d▲ 6.9%
30d▼ 6.8%
1y▲ 76.2%
🏦Market Cap
$11.06B
Mid Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
45
Weak
📊
Analyst Ratings
Price
$126.81
Total
13
Raised
1
Lowered
0
Avg PT
$152.71
H / L
$180 / $90
| Institution | Action | Rating | Date |
|---|---|---|---|
Piper Sandler | Reiterated | Overweight | 2026-07-09 |
Truist Securities | Reiterated | Buy | 2026-07-02 |
Citizens | Reiterated | Market Outperform | 2026-07-01 |
Jefferies | Upgraded | Hold → Buy | 2026-06-30 |
Leerink Partners | Reiterated | Outperform | 2026-06-30 |
Wedbush | Reiterated | Neutral | 2026-06-30 |
BTIG | Reiterated | Buy | 2026-06-30 |
Morgan Stanley | Reiterated | Overweight | 2026-06-02 |
Barclays | Reiterated | Overweight | 2026-03-24 |
Guggenheim | Reiterated | Buy | 2025-10-10 |
JMP Securities | Reiterated | Market Outperform | 2025-09-25 |
LifeSci Capital | Reiterated | Outperform | 2025-07-23 |
Citizens Capital Markets | Reiterated | Market Outperform | 2025-03-18 |
One row per institution, most recent rating